Mark Emberton

38.4k total citations · 10 hit papers
524 papers, 23.0k citations indexed

About

Mark Emberton is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark Emberton has authored 524 papers receiving a total of 23.0k indexed citations (citations by other indexed papers that have themselves been cited), including 396 papers in Pulmonary and Respiratory Medicine, 127 papers in Rheumatology and 97 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark Emberton's work include Prostate Cancer Diagnosis and Treatment (354 papers), Prostate Cancer Treatment and Research (257 papers) and Urinary Bladder and Prostate Research (84 papers). Mark Emberton is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (354 papers), Prostate Cancer Treatment and Research (257 papers) and Urinary Bladder and Prostate Research (84 papers). Mark Emberton collaborates with scholars based in United Kingdom, United States and France. Mark Emberton's co-authors include Hashim U. Ahmed, Caroline M. Moore, Alex Freeman, Clare Allen, Alex Kirkham, Jan van der Meulen, Richard Hindley, Arnauld Villers, Jørgen Nordling and Louise Brown and has published in prestigious journals such as Science, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Mark Emberton

507 papers receiving 22.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

2017 2.2k citations Hashim U. Ahmed, Richard Hindley et al. profile →
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction

2013 916 citations Mark Emberton et al. profile →
Systematic Review of Complications of Prostate Biopsy

2013 735 citations Hashim U. Ahmed, Mark Emberton et al. profile →
Early detection of cancer

2022 706 citations Mark Emberton et al. profile →
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature

2015 613 citations Mark Emberton, Gianluca Giannarini et al. profile →
Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting

2010 555 citations Louise Dickinson, Hashim U. Ahmed et al. profile →
Image-Guided Prostate Biopsy Using Magnetic Resonance Imaging–Derived Targets: A Systematic Review

2012 411 citations Caroline M. Moore, Arnauld Villers et al. profile →
Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging–Ultrasound Fusion Targeted Biopsy: A Systematic Review

2014 345 citations Ian Donaldson, Mark Emberton et al. profile →
Multiparametric MRI for prostate cancer diagnosis: current status and future directions

2019 256 citations Francesco Giganti, Samir S. Taneja et al. profile →
A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer

2018 225 citations Stephanie Guillaumier, Max Peters et al. profile →

Peers

Countries citing papers authored by Mark Emberton

Since Specialization

Citations

This map shows the geographic impact of Mark Emberton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Emberton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Emberton more than expected).

Fields of papers citing papers by Mark Emberton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Emberton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Emberton. The network helps show where Mark Emberton may publish in the future.

Co-authorship network of co-authors of Mark Emberton

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Emberton. A scholar is included among the top collaborators of Mark Emberton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Emberton. Mark Emberton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A semi-supervised prototypical network for prostate lesion segmentation from multimodality MRI 2025 ·Physics in Medicine and Biology ·Yan Wen, Yipeng Hu, Qianye Yang, Yunguan Fu, (unknown), Zhe Min, Shonit Punwani, Mark Emberton, Dean C. Barratt, (unknown), Bernard Chiu	0
2	High-intensity focused ultrasound with visually directed power adjustment for focal treatment of localized prostate cancer: systematic review and meta-analysis 2024 ·World Journal of Urology ·Samuel J. Peretsman, Mark Emberton, Neil Fleshner, Sunao Shoji, Clinton D. Bahler, Larry E. Miller	7
3	Prostate cancer detection and complications of MRI-targeted prostate biopsy using cognitive registration, software-assisted image fusion or in-bore guidance: a systematic review and meta-analysis of comparative studies 2024 ·Prostate Cancer and Prostatic Diseases ·Ugo Giovanni Falagario, Francesco Pellegrino, (unknown), (unknown), Riccardo Bartoletti, Hannes Cash, Christian P. Pavlovich, Mark Emberton, Giuseppe Carrieri, Gianluca Giannarini	5
4	The RECONCILE study protocol: Exploiting image-based risk stratification in early prostate cancer to discriminate progressors from non-progressors (RECONCILE) 2024 ·PLoS ONE ·(unknown), Gerhardt Attard, Shonit Punwani, Francesco Giganti, Alex Freeman, Aiman Haider, Anna Wingate, Norman Williams, (unknown), (unknown), Caroline M. Moore, Mark Emberton, Clément Orczyk	1
5	Imaging modalities for characterising T1 renal tumours: A systematic review and meta‐analysis of diagnostic accuracy 2024 ·SHILAP Revista de lepidopterología ·Hannah Warren, (unknown), (unknown), (unknown), Vinson Wai‐Shun Chan, Richard L. Hesketh, Eleanor Zimmermann, Veeru Kasivisvanathan, Mark Emberton, Maxine Tran, Kurinchi Selvan Gurusamy	1
6	NEphron Sparing Treatment (NEST) for small renal masses: A feasibility cohort-embedded randomised controlled trial comparing percutaneous cryoablation and robot assisted partial nephrectomy 2023 ·European Urology Open Science ·Joana B. Neves, (unknown), (unknown), (unknown), (unknown), Menelaos Pavlou, Miles Walkden, (unknown), (unknown), (unknown), (unknown), Steven Bandula, Elena Pizzo, Veronica Ranieri, Norman Williams, (unknown), Kurinchi Selvan Gurusamy, Mark Emberton, Axel Bex, Maxine Tran	1
7	Picture Perfect: The Status of Image Quality in Prostate MRI 2023 ·Journal of Magnetic Resonance Imaging ·(unknown), (unknown), Louise Dickinson, Alex Kirkham, Shonit Punwani, Aiman Haider, Alex Freeman, (unknown), Mark Emberton, John Hines, Caroline M. Moore, Clare Allen, Francesco Giganti	12
8	Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol 2023 ·BMJ Open ·Aqua Asif, Arjun Nathan, Alexander Ng, Pramit Khetrapal, Vinson Wai‐Shun Chan, Francesco Giganti, Clare Allen, Alex Freeman, Shonit Punwani, Paula Lorgelly, Caroline S. Clarke, Chris Brew‐Graves, Nicola Muirhead, Mark Emberton, Ridhi Agarwal, Yemisi Takwoingi, Jonathan J Deeks, Caroline M. Moore, Veeru Kasivisvanathan	33
9	Prototypical few-shot segmentation for cross-institution male pelvic structures with spatial registration 2023 ·Medical Image Analysis ·Yiwen Li, Yunguan Fu, (unknown), Qianye Yang, Zhe Min, (unknown), Yan Wen, Yipei Wang, J. Alison Noble, Mark Emberton, Matthew J. Clarkson, Henkjan Huisman, Dean C. Barratt, Victor Adrian Prisacariu, Yipeng Hu	14
10	Human airway-like multilayered tissue on 3D-TIPS printed thermoresponsive elastomer/collagen hybrid scaffolds 2020 ·Acta Biomaterialia ·(unknown), Adrián Magaz, Suguo Huo, Arnold Darbyshire, Marilena Loizidou, Mark Emberton, Martin Birchall, Wenhui Song	22
11	Genetic landscape of prostate cancer conspicuity on multiparametric MRI: a protocol for a systematic review and bioinformatic analysis 2020 ·BMJ Open ·Joseph M. Norris, Benjamin S. Simpson, Marina Parry, Clare Allen, Rhys Ball, Alex Freeman, Daniel Kelly, Alex Kirkham, Veeru Kasivisvanathan, Hayley C. Whitaker, Mark Emberton	8
12	Evaluation of functional outcomes after a second focal high‐intensity focused ultrasonography (HIFU) procedure in men with primary localized, non‐metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registry 2020 ·British Journal of Urology ·Catherine Lovegrove, Max Peters, Stephanie Guillaumier, Manit Arya, Naveed Afzal, Tim Dudderidge, Feargus Hosking‐Jervis, Richard Hindley, Henry Lewi, Neil McCartan, Caroline M. Moore, Raj Nigam, Chris Ogden, Raj Persad, Jaspal Virdi, Mathias Winkler, Mark Emberton, Hashim U. Ahmed, Taimur T. Shah, Suks Minhas	26
13	Targeted biopsy of the prostate: does this result in improvement in detection of high‐grade cancer or the occurrence of the Will Rogers phenomenon? 2019 ·British Journal of Urology ·Edward Bass, Clément Orczyk, Alistair Grey, Alex Freeman, Charles Jameson, Shonit Punwani, Navin Ramachandran, Clare Allen, Mark Emberton, Hashim U. Ahmed	13
14	A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol 2017 ·BMJ Open ·Veeru Kasivisvanathan, Fatima Jichi, Laurence Klotz, Arnauld Villers, Samir S. Taneja, Shonit Punwani, Alex Freeman, Mark Emberton, Caroline M. Moore	16
15	Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology? 2014 ·Urologic Oncology Seminars and Original Investigations ·Mohamed Abd-Alazeez, Hashim U. Ahmed, Manit Arya, Clare Allen, Νικόλαος Δικαίος, Alex Freeman, Mark Emberton, Alex Kirkham	23
16	Re: Geometric Evaluation of Systematic Transrectal Ultrasound Guided Prostate Biopsy 2013 ·The Journal of Urology ·Ian Donaldson, Caroline M. Moore, Mark Emberton, Hashim U. Ahmed	0
17	Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy A Pilot Study 2012 ·UCL Discovery (University College London) ·Hashim U. Ahmed, (unknown), Neil McCartan, Alex Kirkham, (unknown), Alex Freeman, Mark Emberton	6
18	The NHS patient information lottery: it is whom you see rather than what you need. 2000 ·PubMed ·P. G. Meredith, Mark Emberton	3
19	From surgical audit to clinical effectiveness. 1998 ·PubMed ·Mark Emberton, (unknown)	3
20	Comparative audit: a new method of delivering audit. 1991 ·PubMed ·Mark Emberton, (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact